Genomic Valley Biotech Limited (BOM:539206)
India flag India · Delayed Price · Currency is INR
35.11
+1.67 (4.99%)
At close: Jun 23, 2026

Genomic Valley Biotech Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
0.260.450.060.410.03
Cash & Short-Term Investments
0.260.450.060.410.03
Cash Growth
-42.01%644.62%-85.30%1441.91%-76.61%
Accounts Receivable
23.1822.1425.322.17-
Other Receivables
--0.020.020.15
Receivables
23.1822.1425.3222.20.15
Inventory
2.842.84---
Other Current Assets
0.70.783.723.1611.19
Total Current Assets
26.9826.2229.125.7711.37
Property, Plant & Equipment
0.050.090.020.0317.47
Long-Term Investments
--0.174.354
Other Intangible Assets
----0.08
Long-Term Deferred Tax Assets
----0
Other Long-Term Assets
0.059.0514.0514.055.05
Total Assets
42.543.5743.3444.237.97
Accounts Payable
0.060.16.026.11-
Accrued Expenses
0.110.310.031.740.25
Current Income Taxes Payable
-0.85---
Other Current Liabilities
3.043.331.871.091.9
Total Current Liabilities
3.214.587.918.932.14
Long-Term Deferred Tax Liabilities
00.0100-
Other Long-Term Liabilities
----7.05
Total Liabilities
3.214.587.928.949.19
Common Stock
30.5530.5530.5530.5530.55
Retained Earnings
-5.972.412.26-4.22
Comprehensive Income & Other
8.742.472.472.472.47
Shareholders' Equity
39.2838.9835.4235.2728.79
Total Liabilities & Equity
42.543.5743.3444.237.97
Net Cash (Debt)
0.260.450.060.410.03
Net Cash Growth
-42.01%644.62%-85.30%1441.91%-
Net Cash Per Share
0.090.150.020.140.01
Filing Date Shares Outstanding
3.053.053.053.053.05
Total Common Shares Outstanding
3.053.053.053.053.05
Working Capital
23.7821.6421.1916.849.23
Book Value Per Share
12.8812.7611.6011.559.42
Tangible Book Value
39.2838.9835.4235.2728.71
Tangible Book Value Per Share
12.8812.7611.6011.559.40
Land
----20.55
Machinery
-0.130.032.973.27